Company Profile

Acomhal Research Inc
Profile last edited on: 4/15/22      CAGE: 7LJG5      UEI: QCZ3GLF8WNP5

Business Identifier: Biotech developing novel treatments targeting cancer cells.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

709 South Jefferson Street Suite 4
Roanoke, VA 24016
   (415) 845-2992
Location: Single
Congr. District: 06
County: Roanoke city

Public Profile

Acomhal Research Inc, -- a biotech spun out of the Virginia Tech Carilion Research Institute -- is structured around working on an innovative therapeutic drug to target chemoresistant cancer cells and prevent tumor recurrence in glioblastoma. With the firm's described mission is that of development of novel and effective therapeutic approaches targeting tumor recurrence and metastasis, the principals are developing new proprietary drugs more effectively to treat primary cancer tumors n a manner that result in less recurrence and fewer metastases, thereby improving patient outcomes. A particular compound being studied by Acomhal has the potential to target cancer stem cells, which are the seeds from which a number of different tumors are thought to grow.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Rob Gourdie -- Founder

  Samy Lamouille -- Co-Founder and CEO

Company News

There are no news available.